Company Search:
Advanced Search
Sponsored Links
Redx Pharma PLC Company Snapshot
Redx Pharma PLC operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Redx Pharma PLC with three other companies in this sector in UNITED KINGDOM : Deepmatter Group PLC (2019 sales of £1.20 million [US$1.50 million] of which 97% was InfoChem), Fusion Antibodies PLC (£2.18 million [US$2.73 million] ), and Avacta Group Plc (£3.89 million [US$4.86 million] of which 60% was Life Sciences).

Sales Analysis.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Redx Pharma PLC
  Stock Performance Chart for Redx Pharma PLC
  Stock Data: Recent Stock Performance:
  Current Price (7/3/2020): 37.50p
(Figures in Pounds Sterling)
1 Week 114.3%   13 Weeks 200.0%  
4 Weeks 150.0%   52 Weeks 500.0%  
Redx Pharma PLC Key Data:
  Ticker: REDX Country: United Kingdom
  Exchanges: LON Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2019 Sales 3,131,000
(Year Ending Jan 2020).
Employees: 52
  Currency: Pounds Sterling Market Cap: 71,253,264
  Fiscal Yr Ends: September Shares Outstanding: 190,008,703
  Share Type: Ordinary Closely Held Shares: 26,809,691
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.